chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Asthma; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products ADALIMUMAB (HUMIRA) for Psoriatic arthritis and ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    The patient's past medical history included Psoriatic arthritis.   On 07-Nov-2012, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. In November 2021, the patient experienced ASTHMA (Asthma). At the time of the report, ASTHMA (Asthma) had not resolved.            No concomitant medications were reported. No treatment drugs were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
symptoms of bell palsy; Numbness of upper and lower lip on right side.; sore muscles in neck; sore muscles in neck and shoulder; watery eyes; muscle aches; pains; problems in sleeping; This is a spontaneous report from a contactable consumer via the Pfizer sponsored program. This is a spontaneous report from a contactable consumer (the patient).  A 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264), via an unspecified route of administration, in the left arm on 01Feb2021 at 14:30 (at the age of 76-years) as a single dose for COVID-19 immunization. Medical history included chronic asthma, nasal polyps, vestibular schwannoma, alopecia, gastrooesophageal reflux disease. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Feb2021 at 07:00 AM, the patient experienced symptoms of bell palsy, numbness of upper and lower lip on right side, sore muscles in neck and shoulder, watery eyes, muscle aches, pain, problems in sleeping. He felt the symptoms after the first dose.  The patient visited the emergency room/ department or urgent care due to the events. The patient did not received treatment for the events. The clinical outcome of the events was not recovered.
Swollen arm on same side as shot. Pt dx with cellulitis. Abx successfully cured.
12/3/21: 58yr old male presents today  for cough, congestion, fever, fatigue, diarrhea and body aches. Patient states that his symptoms started last night. Works at (PRVICAY) and was exposed to a someone who tested positive. He  Had a positive test today. Would like to do the antibody infusion on Monday so needs a lab confirmed test in the clinic. COVID+  Received monoclonal antibody on 12/6/21.
pt recv vax 6NOV96 & 4FEB97 pt devel an itchy rash of raised papules not classic chickenpox on both legs & trunk;devel a mild, low grade fever;exp nasal congestion;diarrhea, red eyes, vomiting noted;VZ IgG <1.8 (titer negative); WBC 7.4;
PATIENT'S HUSBAND CAME IN AND STATED THAT SHE RECEIVED THE SHOT 2 WEEKS AGO. HER ARM WAS SORE AFTER RECEIVING. SEVERAL DAYS LATER HER ARM STARTED TO HAVE A LIMITED RANGE OF MOTIUON
Patient was diagnosed, admitted to hospital for 7 days and discharged home without O2, he got his 1 dose of Moderna vaccine after 45 days of COVID19 diagnosis. With in 8 hours patient started developing Shortness of breath, Chest pain and myalgia so admitted to ICU, intubated and found to have Diffuse alveolar hemorrhage and Myocarditis.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 59-year-old, adult patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6-degree Celsius. On 15-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250230 (as reported), expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. The reported batch number (250230), does not match Seqirus batch numbers, however, because the reporter named Seqirus product 'FLUCELVAX QIVc' as the suspect vaccine, this report has been conservatively entered as a Seqirus case. At the time of this report, no adverse event was reported. This case 201805476 was crossed linked to original cases 201804863 due to same reporter.
I haven?t had a headache for years until this weekend. Sore and achey around and behind left eye and left forehead.
Patient complained of mild pain at first. Then over the course of a few days, he reported increasing pain and discomfort. Additionally, he presented as guarding the arm. The arm then subsequently was found to have a rash associated with it after a few days. The rash originally was localized to the shoulder area, however, over the course of an additional 48 hours spread down the entire arm to the wrist. The rash was red, raised in patched, and blistering. The overall appearance was that of a shingles rash. The patient reported severe pain, itching and general discomfort in the rash and pain in moving the arm.  The patient was first evaluated by a doctor on 1/9/21 at an urgent care. At this time the patient was given Triamcinolone Acetonide and advised to follow-up the next day with primary peds. The patient then was seen again on 1/10/21 by their primary pediatrician. The patient was then given Acyclovir oral.  The patient continues to have a unilateral rash on the arm, however, the blisters have broken and no new ones have developed.
Approximately two weeks after receiving the second dose of the Pfizer/BioNTech vaccine I went to my primary care doctor for a physical.  As part of normal screening,  labs were ordered, and as a result of those tests, I learned that my body had effectively stopped making thyroid stimulating hormone (TSH).  I was referred to endocrinologist who ordered additional lab work and a thyroid uptake scan.  The scan resulted in a diagnosis of subacute thyroiditis.  My thyroid levels returned to normal in August of 2021 but I'm still being followed by endocrinologist.
pt recv vax & devel chills, noc sweats, body aching, lt arm pit edema, 2 red streaks from lt deltoid to arm pit & tightness in chest when deep breathing;6JAN98 seen @ clinic;augmentin prescribed x 10 days;pt states feel better today 6JAN98
This spontaneous case was reported by a patient and describes the occurrence of JOINT DISLOCATION (shoulder dislocated) and ARTHRALGIA (Joint pain in her elbows, wrists, and shoulders which then spread to her knees, toes and hips.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 prophylaxis. The patient's past medical history included Neck injury and Nerve pain. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced JOINT DISLOCATION (shoulder dislocated) and ARTHRALGIA (Joint pain in her elbows, wrists, and shoulders which then spread to her knees, toes and hips.). At the time of the report, JOINT DISLOCATION (shoulder dislocated) had resolved and ARTHRALGIA (Joint pain in her elbows, wrists, and shoulders which then spread to her knees, toes and hips.) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: showed shoulder was fine. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medication was provided. The patient shoulder was loosened up. Prior to receiving the Moderna vaccine, patient was being treated for a neck injury and nerve pain, and had continued treatment following vaccination. Neurologist stated the pain was not related to neck injury. This pain has continued up until today. Second dose of Moderna was taken on 11-Mar-2021, Lot number was unknown and expiration date 06-Sep-2021. Patient has taken Pfizer vaccine on 28-Feb-2022. On 01-JUN-2022, patient tested positive for COVID-19. Patient has experienced symptoms including coughing, and cold/flu like symptoms. The joint pain also has become worse. Patient took Tylenol, and ivy leaf cough syrup for symptoms. Patient hands are worse with gripping and toes are worse at night since having COVID-19. Patient has tried to take anti-inflammatories but the kidney doesn't like it. The pain has been so bad at times that  has been in tears. Primary doctor also gave her an injectable anti-inflammatory which helped. No treatment medication was provided.
10 x 6 cm hyperemia warm lesion right thigh - non tender around injection site cellulitis right thigh
One day post vax, this pt returned to office with raised, irregular lesions on face, trunk, and proximal extremities . Hep B is the only vax not previously received. Dxed with urticaria.
No additional adverse events reported; improperly stored vaccines may have been administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, and previous drugs reactions or allergies were not provided.  On 23-DEC-2019, the patient was vaccinated with an improperly stored (product storage error), pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (Therapy type: Digital Data Logger), lot number S003872 and expiration date 22-DEC-2020 for prophylaxis (strength, dose, dose number, frequency, route of administration, and anatomical location, were not provided).  The vaccine was stored at a temperature above 47 degree Fahrenheit (47.1 Fahrenheit), for a timeframe of 8 to 16 minutes, with no previous temperature excursion. The call was due to a Digital Data Logger.  No additional adverse events were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA009007:
"Moderna COVID-19 Vaccine "   For the most part I had normal flu like symptoms, but at midnight of the second day I had a severe vertigo attack.  I could not walk, spinning was severe and it caused vomiting.   The third day I could not get out of bed because of the spinning and inability to walk without falling.  I was able to get up by afternoon and began to feel better by dinner time, but by 11:00 pm I had another severe attack of vertigo.  It is now a week after my second dose and I am still struggling with vertigo.
redness at injection site measuring 4cm lasting for 5 days.  fever, chills, myalgia, fatigue and mild headache beginning around 20 hours after vaccination and lasting around 15 hours.
About 10 minutes after pt received vaccine (around 10:21) she began to feel nauseated and dizzy.  She began vomiting,  and her throat became "itchy."  Vital signs stable.   She then complained of her lips feeling numb. Epi Pen was given at 10:33 am.  Pt assisted to lie on floor. Pt responsive and following commands, O2 sats noted to be 95% and pulse to palpation was in the 40's, now unable to hear BP.  Pt says she didn't think epi had helped, 2nd epi pen given.   Pt became unresponsive, O2sats in mid to high 80/s, pulse 120, EMS now here (around 10:40).  EMS transported pt to hospital.
This spontaneous report was received from personnel from the Immunization Program referring to 2 patients of unknown gender and age. On an unknown date these patients were vaccinated with PNEUMOVAX23 (lot number and expiration date not specified) (dose and route not reported). On an unknown date the patients were diagnosed with cellulitis after the administration of PNEUMOVAX23. The outcome for cellulitis was unknown at the time of the report. No treatment information was reported. Additional information is not expected.
Swelling/soreness at injection site, increased ringing in ears, ringing in head, dizziness, vertigo, waves of nerve sensation through head at intervals, nausea, fatigue, disorientation, headache, ear pain, plugged ears, metal mouth, loss of appetite.
sudden itchiness on area surrounding injection site at night after 1.5 week of injection and continue to persist for the following days, a small red bump, the area around the injection site the size of a small child?s palm is pink/light red in color
[Pfizer Covid Vaccine] use for COVID-19 under Emergency Use Authorization  (EUA): Patient received 2 covid vaccine series and still presented with covid-19 pneumonia. 86-year old male with history of aortic regurgitation, arteriosclerotic vascular disease, BPH, carotid atherosclerosis, colon polyps, elevated LFTs, herpes zoster, irritable bowel syndrome, macular degeneration, pulmonary emphysema, right renal mass s/p right nephrectomy, diabetes
This spontaneous report as received from a 67 year old male patient referred to himself. The patient was allergy to anything with a "zone" in it, included prednizone and cortisone. The patient could take cremes but nothing that went inside. The patient's medical history included asthma attack. The patient's concurrent condition included blood pressure issue that was caused by the asthma. On an unknown date in approximately August 2013 (6 to 8 months ago) the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency, route and lot# not reported). Second suspect therapies included LISINOPRIL for blood pressure issue was given at the end of February 2014. On an unknown date in February 2014 (at the end of February 2014), less than a year after receiving the vaccine the patient came down with undiagnosed red itchy patches on multiple areas of his body immediately after taking lisinopril for the blood pressure issue that was caused by the asthma he had. Lisinopril was known to cause hives. The patient stated that he thinks he had shingles currently but that his doctor said he didn't think it was shingles but rather hives. The patient said that when he touched the bumps it "activated them to be itchy", it's not on the skin, but under the skin, like you had ants waking on you". He said that he had it in 5 spots on his body, "legs. belly, head, back of the neck and the tops of his arms" up to his elbow and "they took turns itching. One area would stop itching and another area would pick up." The patient sought medical attention and the doctor issued him a special body wash and a creme to ease the symptoms of the shingles/hives. No lab diagnostics studies were performed. At the time of reporting, the patients outcome was unknown. Additional information is not expected.
red splotches w/bumps over entire body-t102 R approx 18 hrs p/shot given-taken to hosp-adm given DPH will be d/c 14JAN95;
Tingling feeling of lower extremities; Muscle spasm; Missed the 2nd dose of Moderna vaccine; Sweating; Burning chest and arms; Dizziness; Rash for 7 days; Body aches; Headaches; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling feeling of lower extremities), MUSCLE SPASMS (Muscle spasm), PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna vaccine), HYPERHIDROSIS (Sweating) and BURNING SENSATION (Burning chest and arms) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A (or) 011L2019?) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), BURNING SENSATION (Burning chest and arms), DIZZINESS (Dizziness), RASH (Rash for 7 days), MYALGIA (Body aches), HEADACHE (Headaches) and NAUSEA (Nausea). On an unknown date, the patient experienced PARAESTHESIA (Tingling feeling of lower extremities), MUSCLE SPASMS (Muscle spasm) and PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna vaccine). The patient was treated with DEXAMETHASONE for Adverse event, at a dose of UNK dosage form and TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, PARAESTHESIA (Tingling feeling of lower extremities) and MUSCLE SPASMS (Muscle spasm) had not resolved and PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna vaccine), HYPERHIDROSIS (Sweating), BURNING SENSATION (Burning chest and arms), DIZZINESS (Dizziness), RASH (Rash for 7 days), MYALGIA (Body aches), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Patient was advised by allergist not to take second dose. The patient did some blood work by the recommendation of allergist and report came normal.So the allergist referred the patient to contact the Neurologist for the symptoms persisting.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Anatomical location of vaccination, treatment details and contact details were updated. On 05-May-2021: Events and lab data updated.
Appendicitis; Drop in Blood Pressure; This spontaneous case was reported by a consumer and describes the occurrence of APPENDICITIS (Appendicitis) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Irritable bowel syndrome, Anxiety and Blood pressure high.   On 09-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, the patient experienced BLOOD PRESSURE DECREASED (Drop in Blood Pressure). On 03-Jun-2021, the patient experienced APPENDICITIS (Appendicitis) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on sometime in June 2021 due to APPENDICITIS. The patient was treated with Surgery for Appendicitis. On 09-May-2021, BLOOD PRESSURE DECREASED (Drop in Blood Pressure) had resolved. On 04-Jun-2021, APPENDICITIS (Appendicitis) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-May-2021, Blood pressure measurement: drop (Low) Drop in Blood Pressure.   mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  The patient stated that abdomen started hurting really bad. The patient went to the emergency room and diagnosed it as appendicitis. The patient had emergency surgery to remove appendix and recovering well. The patient was not sure if the appendicitis was because of the first dose of the vaccine.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: The follow up document was received from the initial reporter: New event blood pressure drop and lab data were added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
PAINFUL BURNING SWOLLEN THROAT AND NECK, PAINFUL BURNING SWOLLEN TONGUE, PAINFUL SWOLLEN GLANDS; PAINFUL BREATHING; PUSS ON BACK OF TONGUE. BURNING ITCHING NOSE AND SINUS`S; PAIN IN EYES; HEADACHE; COUGH
Systemic: Dizziness / Lightheadness-Severe, Systemic: DIZZINES AND DISORIENTED-Severe, Systemic: Hypertension-Severe
01/26/2003 seen by physician in office. Tonsils mildly enlarged, pink, no exudate: are a between left post mandible amd mastoid t t swollen. Slight redness and heat. None over mandible. Started 01/25/2003, mother noticed while bathing him. Dx: Parotitis.
Information has been received from a health care coordinator and a nurse concerning a 2 month old female with no pertinent medical history and no known allergies who on 06-NOV-2007 was vaccinated intramuscularly in the left thigh with pneumococcal 23v polysaccharide vaccine (0.5 mL). Concomitant vaccination on 06-NOV-2007 included Hib conj vaccine (unspecified carrier) (manufacturer unknown), poliovirus vaccine (manufacturer unknown), diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown) and hepatitis B vaccine, recomb (manufacturer unknown). The nurse reported that the patient was supposed to receive PREVNAR when pneumococcal 23v polysaccharide vaccine was given by mistake. The nurse stated that the mistake occurred because the physician may have ordered the wrong vaccine and mentioned it can be confusing as far as which vaccine needs to be given to which age group. No adverse reaction was reported post vaccination. Medical attention was sought in the physician's office. In follow-up from the health worker, it was reported that the error was "strictly human error" on the medical assistant's part, two different ones unfortunately." The reporter stated that "it was not a matter of product confusion, the vaccines were in different containers on different shelves, the medical assistant just made a mistake." this is one of two reports from the same source. Additional information has been requested.
Small, bumpy, itchy rash at injection site about 4 in diameter with a few stray bumps around the elbow starting a few hours after vaccination.  Bumps started to fade 4 days later.
Rec'd #2 dose Engerix-B & experienced Coryza sxs 4 days later;
On 9/20/2022 I started experiencing facial numbness on the right side. I had a neurological screening to rule out a stroke and it was normal. Dx Hypesthesia and was prescribed an antiviral medication in the event that I get Shingles.